샘플 요청 목록

 카트 문의
시장보고서
상품코드
1882094

세계의 패혈증 진단약 시장

Sepsis Diagnostics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 173 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 패혈증 진단 시장은 2030년까지 12억 달러에 달할 전망

2024년에 7억 4,540만 달러로 추정되는 세계의 패혈증 진단 시장은 2024-2030년의 분석 기간에 CAGR 7.5%로 성장하며, 2030년까지 12억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석 대상 부문의 하나인 미생물학 기술은 9.1%의 CAGR을 기록하며, 분석 기간 종료시까지 7억 4,980만 달러에 달할 것으로 예측됩니다. 면역측정 기술 부문의 성장률은 분석 기간에 4.8%의 CAGR로 추정되고 있습니다.

미국 시장은 1억 9,330만 달러로 추정되는 한편, 중국은 12.8%의 CAGR로 성장할 것으로 예측됩니다.

미국에서 패혈증 진단 시장은 2024년에 1억 9,330만 달러로 추정되고 있습니다. 세계 2위의 경제 규모를 자랑하는 중국은 2024-2030년의 분석 기간에 CAGR 12.8%로 추이하며, 2030년까지 예측 시장 규모 2억 9,940만 달러에 달할 것으로 전망되고 있습니다. 기타 주목할 만한 지역별 시장 분석으로는 일본과 캐나다를 들 수 있으며, 각각 분석 기간 중 3.0%, 7.5%의 CAGR로 성장할 것으로 예측됩니다. 유럽에서는 독일이 약 3.9%의 CAGR로 성장할 것으로 예측됩니다.

세계의 패혈증 진단 시장 - 주요 동향과 촉진요인의 개요

고급 패혈증 진단에 대한 수요가 빠르게 증가하는 이유

감염에 대한 신체의 과도한 반응으로 인해 발생하는 생명을 위협하는 상태인 패혈증은 여전히 전 세계 주요 사망 원인 중 하나입니다. 환자 예후 개선과 의료비 절감에 필수적인 조기 발견과 적시 개입의 필요성 때문에 고급 패혈증 진단법에 대한 수요가 빠르게 증가하고 있습니다. 기존 진단법은 시간적 지연, 정확성, 초기 단계의 패혈증 식별 복잡성 등의 문제가 종종 발생했습니다. 이에 따라 병원과 임상검사실에서는 분자진단, 신속항원검사, 바이오마커 기반 검사 등 혁신적인 진단 솔루션을 도입하여 패혈증의 정확하고 신속한 진단이 가능해졌습니다. 특히 중환자실(ICU)과 응급실에서의 높은 패혈증 발생률은 전 세계에서 이러한 첨단 진단 툴의 도입을 더욱 촉진하고 있습니다.

기술 발전은 패혈증 진단에 어떤 영향을 미치고 있는가?

기술 발전은 패혈증 진단의 상황을 크게 개선하여 정확성, 속도, 신뢰성을 향상시키고 있습니다. 중합효소연쇄반응(PCR)과 차세대 염기서열분석(NGS)을 포함한 분자진단 기술의 혁신으로 병원체와 항생제 내성 프로파일을 신속하게 파악할 수 있게 되어 표적 치료를 촉진할 수 있게 되었습니다. 또한 자동화 플랫폼과 POC(Point-of-Care) 디바이스의 개발로 진단 기능이 병상에 더 가까이 다가와 결과 도출 시간을 단축하고 임상적 판단을 개선하고 있습니다. 또한 AI와 머신러닝 알고리즘이 진단 툴에 통합되어 복잡한 데이터세트를 분석하여 패혈증 결과를 보다 정확하게 예측할 수 있게 되었습니다. 또한 프로칼시토닌(PCT), C 반응성 단백질(CRP), 젖산 수치 등 바이오마커 기반 검사의 보급으로 임상의는 패혈증의 중증도 및 진행 상황에 대한 중요한 정보를 얻을 수 있으며, 고급 진단 시장의 확대를 주도하고 있습니다.

패혈증 진단의 채택을 주도하는 시장 부문은?

패혈증 진단 시장은 기술, 제품 유형, 병원체, 검사 유형, 최종사용자, 지역별로 분류됩니다. 주요 기술로는 분자진단, 면역측정법, 미생물학, 유세포분석법 등이 있으며, 신속하고 정확한 병원체 동정 능력으로 인해 분자진단이 선도적인 위치에 있습니다. 제품 유형은 기기 및 시약에서 소프트웨어 및 서비스까지 다양하며, 지속적인 수요가 있는 시약 및 소모품이 가장 큰 비중을 차지하고 있습니다. 패혈증 진단의 대상이 되는 병원체에는 세균성, 진균성, 바이러스성 병원체가 포함됩니다. 임상 현장에서 세균 감염의 높은 발생률로 인해 세균성 패혈증 진단이 가장 흔합니다. 패혈증 진단의 최종사용자에는 병원, 병리검사실, 연구소 등이 포함됩니다. 중환자실(ICU)과 응급실에서의 패혈증 환자 수가 많기 때문에 병원이 시장을 독점하고 있습니다. 지역별로는 첨단화된 의료 인프라와 높은 인지도에 힘입어 북미와 유럽이 주요 시장으로 부상하고 있습니다. 한편, 아시아태평양은 의료 투자 증가와 패혈증에 대한 인식이 높아지면서 고성장 지역으로 부상하고 있습니다.

패혈증 진단 시장의 주요 성장 요인은 무엇인가?

패혈증 진단 시장의 성장은 패혈증 유병률 증가, 신속하고 정확한 진단 툴의 필요성, 분자진단 및 바이오마커 진단 기술의 발전 등 여러 요인에 의해 주도되고 있습니다. 빠른 결과 제공과 높은 민감도를 구현할 수 있는 Point-of-Care 기기 및 자동화 플랫폼의 개발로 병원 및 진단검사실에서 시장 도입을 촉진하고 있습니다. 맞춤의료와 표적치료에 대한 관심이 높아지면서 병원균의 정밀한 동정 및 항생제 감수성 검사를 가능하게 하는 첨단 패혈증 진단법의 활용이 확대되고 있습니다. 패혈증 사망률을 낮추고 조기 발견을 개선하기 위한 정부 주도의 노력과 의료 프로그램 증가는 시장 성장의 새로운 기회를 창출하고 있습니다. 또한 새로운 패혈증 바이오마커, AI 기반 진단 툴, 신속한 다중 검사법에 대한 R&D 투자 증가는 시장 확대를 더욱 촉진하고 있습니다.

부문:

기술별(미생물학, 면역측정법, 분자진단, 기타 기술), 제품별(혈액 배양 배지, 어세이 키트·시약, 기기, 소프트웨어), 검사 유형별(검사실, POC(Point-of-Care))

조사 대상 기업의 예

  • Abbott Diagnostics
  • Axis-Shield Diagnostics Ltd
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bruker Corporation
  • Cytosorbents Corporation
  • Danaher Corporation
  • EKF Diagnostics Holdings PLC
  • Immunexpress Inc.
  • Luminex Corporation
  • Mitsubishi Chemical Europe
  • Response Biomedical Corp.
  • Roche Diagnostics(Schweiz) AG
  • T2 Biosystems
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

검증된 전문가 컨텐츠와 AI 툴을 통해 시장 및 경쟁 정보 분석을 혁신하고 있습니다.

Market Glass, Inc.는 LLM이나 산업 특화형 SLM을 조회하는 일반적인 방식이 아닌, 전 세계 도메인 전문가들이 엄선한 컨텐츠 리포지토리를 구축했습니다. 여기에는 비디오 전사, 블로그, 검색엔진 조사, 그리고 방대한 양의 기업, 제품/서비스, 시장 데이터가 포함됩니다.

관세 영향 계수

Market Glass, Inc.가 본사 소재지, 생산기지, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁 변화를 예측하면서 지역적 시장에 대한 관세의 영향을 반영했습니다. 이러한 복잡하고 다면적인 시장 현실은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 경쟁사에게 다양한 영향을 미치며, 미시적 및 거시적 시장 역학에도 영향을 미칩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.12.11

Global Sepsis Diagnostics Market to Reach US$1.2 Billion by 2030

The global market for Sepsis Diagnostics estimated at US$745.4 Million in the year 2024, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Microbiology Technology, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$749.8 Million by the end of the analysis period. Growth in the Immunoassay Technology segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$193.3 Million While China is Forecast to Grow at 12.8% CAGR

The Sepsis Diagnostics market in the U.S. is estimated at US$193.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$299.4 Million by the year 2030 trailing a CAGR of 12.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 7.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Sepsis Diagnostics Market - Key Trends and Drivers Summarized

Why Is the Demand for Advanced Sepsis Diagnostics Growing Rapidly?

Sepsis, a life-threatening condition resulting from the body’s extreme response to infection, remains a leading cause of mortality worldwide. The demand for advanced sepsis diagnostics is rapidly increasing due to the need for early detection and timely intervention, which are critical for improving patient outcomes and reducing healthcare costs. Traditional diagnostic methods often face challenges related to time delays, accuracy, and the complexity of identifying sepsis at an early stage. In response, hospitals and clinical laboratories are increasingly adopting innovative diagnostic solutions, such as molecular diagnostics, rapid antigen tests, and biomarker-based assays, to enable precise and swift diagnosis of sepsis. The high prevalence of sepsis, particularly in intensive care units (ICUs) and emergency departments, is further driving the adoption of these advanced diagnostic tools globally.

How Are Technological Advancements Impacting Sepsis Diagnostics?

Technological advancements are significantly enhancing the sepsis diagnostics landscape, offering greater accuracy, speed, and reliability. Innovations in molecular diagnostics, including polymerase chain reaction (PCR) and next-generation sequencing (NGS), are enabling rapid identification of pathogens and their antibiotic resistance profiles, facilitating targeted therapy. Additionally, the development of automated platforms and point-of-care (POC) devices is bringing diagnostic capabilities closer to the bedside, reducing the time-to-results and improving clinical decision-making. AI and machine learning algorithms are also being integrated into diagnostic tools to analyze complex datasets and predict sepsis outcomes more accurately. Furthermore, the rise of biomarker-based tests, such as procalcitonin (PCT), C-reactive protein (CRP), and lactate levels, is providing clinicians with critical information on the severity and progression of sepsis, driving the market for advanced diagnostics.

Which Market Segments Are Leading the Adoption of Sepsis Diagnostics?

The sepsis diagnostics market is segmented by technology, product type, pathogen, testing type, end-user, and region. Key technologies include molecular diagnostics, immunoassays, microbiology, and flow cytometry, with molecular diagnostics leading due to their rapid and precise pathogen identification capabilities. Product types range from instruments and reagents to software and services, with reagents and consumables accounting for the largest share owing to their recurring demand. Pathogens covered in sepsis diagnostics include bacterial, fungal, and viral pathogens, with bacterial sepsis diagnostics being the most common due to the high incidence of bacterial infections in clinical settings. End-users of sepsis diagnostics include hospitals, pathology labs, and research institutes, with hospitals dominating the market due to the high volume of sepsis cases in ICUs and emergency departments. Geographically, North America and Europe are the leading markets due to advanced healthcare infrastructure and high awareness, while Asia-Pacific is emerging as a high-growth region driven by increasing healthcare investments and rising sepsis awareness.

What Are the Key Drivers of Growth in the Sepsis Diagnostics Market?

The growth in the sepsis diagnostics market is driven by several factors, including the increasing prevalence of sepsis, the need for rapid and accurate diagnostic tools, and advancements in molecular and biomarker-based diagnostics. The development of point-of-care devices and automated platforms that provide quick turnaround times and high sensitivity is driving market adoption across hospitals and diagnostic labs. The growing focus on personalized medicine and targeted therapies is expanding the use of advanced sepsis diagnostics that enable precise pathogen identification and antibiotic susceptibility testing. The rise of government initiatives and healthcare programs aimed at reducing sepsis mortality rates and improving early detection is creating new opportunities for market growth. Additionally, the increasing investments in R&D for novel sepsis biomarkers, AI-based diagnostic tools, and rapid multiplex assays are further supporting market expansion.

SCOPE OF STUDY:

The report analyzes the Sepsis Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Microbiology, Immunoassay, Molecular Diagnostic, Other Technologies); Product (Blood Culture Media, Assay Kits & Reagents, Instruments, Software); Testing Type (Laboratory, Point-of-Care)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 46 Featured) -

  • Abbott Diagnostics
  • Axis-Shield Diagnostics Ltd
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bruker Corporation
  • Cytosorbents Corporation
  • Danaher Corporation
  • EKF Diagnostics Holdings PLC
  • Immunexpress Inc.
  • Luminex Corporation
  • Mitsubishi Chemical Europe
  • Response Biomedical Corp.
  • Roche Diagnostics (Schweiz) AG
  • T2 Biosystems
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Sepsis Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Sepsis Cases Globally Spurs Demand for Advanced Diagnostic Solutions
    • Technological Advancements in Molecular Diagnostics Propel Innovation in Sepsis Testing
    • Increasing Focus on Early Detection and Rapid Diagnosis Expands Addressable Market Opportunity
    • Growth of Point-of-Care Testing (POCT) for Sepsis Strengthens Business Case for Diagnostic Tools
    • Focus on Enhancing Sensitivity and Specificity of Sepsis Diagnostic Tests Drives Adoption
    • Emergence of Automated and AI-Driven Diagnostic Systems Generates New Market Opportunities
    • Rising Use of Biomarker-Based Diagnostics in Sepsis Detection Boosts Market Potential
    • Shift Towards Personalized Medicine and Targeted Therapies Expands Market Reach
    • Growing Emphasis on Sepsis Management in Critical Care Units Spurs Market Innovation
    • Emergence of Sepsis Diagnostics as a Key Component in Antimicrobial Stewardship Programs Expands Adoption
    • Expansion of Diagnostic Applications in Low- and Middle-Income Countries Creates New Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sepsis Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sepsis Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Sepsis Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Sepsis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Microbiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Immunoassay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Molecular Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Molecular Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Molecular Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Blood Culture Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Blood Culture Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Blood Culture Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Assay Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Assay Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Assay Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Laboratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Point-of-Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Point-of-Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Point-of-Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • JAPAN
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • CHINA
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • EUROPE
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Sepsis Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Sepsis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • FRANCE
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • GERMANY
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Sepsis Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Sepsis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • INDIA
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Sepsis Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Sepsis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Sepsis Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Sepsis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
  • AFRICA
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제